TAKE Limited FY26 Results: Net profit rises 477% to ₹108.5 million
- Consolidated net profit rose 477% YoY to ₹108.5 million in FY26
- Revenue from operations reached ₹541.9 million, up from nil in FY25
- Discontinued operations contributed ₹65.9 million to total profits
- Auditors issued qualified opinion on recoverability of tax assets
- Company launched AI-health platform Take.Health and entered longevity sector

*this image is generated using AI for illustrative purposes only.
TAKE Limited reported a consolidated net profit of ₹108.5 million for FY26, a sharp turnaround from a profit of ₹37.5 million in the prior year that was heavily influenced by one-off gains. The company's revenue from operations stood at ₹541.9 million, emerging from nil in FY25 as its new AI-driven healthcare platforms began generating commercial traction.
The Chennai-based firm, formerly known as TAKE Solutions Limited, submitted its annual report for the financial year ended March 31, 2026, to stock exchanges on September 7, 2026. The results reflect the early stages of a strategic pivot toward digital health and longevity services.
Financial Performance
On a consolidated basis, total income reached ₹608.7 million, up nearly 500% year-on-year. Profit from continuing operations was ₹42.6 million, compared to ₹7.4 million in FY25. The standalone entity also returned to profitability, posting a net profit of ₹27.2 million against a net loss of ₹697.4 million in the previous year.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Consolidated Revenue | ₹541.9 million | Nil | New |
| Consolidated Net Profit | ₹108.5 million | ₹37.5 million | +189% |
| Standalone Net Profit | ₹27.2 million | (₹697.4 million) | Turnaround |
What the Numbers Show
The consolidated profit figure includes ₹65.9 million from discontinued operations, which accounts for roughly 61% of the total net profit. This indicates that while the core business is stabilizing, the bottom line remains significantly supported by non-recurring items related to past business units. Furthermore, the standalone entity recorded zero revenue from operations, suggesting that all operational income is currently generated through subsidiaries rather than the holding company itself.
Strategic Initiatives
Management highlighted several key developments during the year:
- Launch of Take.Health, an AI-driven consumer health platform.
- Development of a Unified AI Platform for enterprise healthcare infrastructure.
- Entry into the longevity and anti-ageing market with science-backed nutraceuticals.
- Establishment of an Innovation Fund with an initial corpus of ₹50 million to invest in deep-tech health startups.
Audit Qualifications
Statutory auditors M/s. A. Raghavendra Rao & Associates issued a qualified opinion on both standalone and consolidated financial statements. The qualification relates to income tax assets totaling ₹87.6 million (standalone) and ₹129.2 million (consolidated), which are pending adjudication in various forums. The auditors noted they could not confirm the ultimate realizable value of these assets.
Corporate Governance
The Board appointed Mr. Sunil Patra as Managing Director and CFO in May 2026 to fill casual vacancies. The company faced regulatory fines for delays in appointing a Company Secretary and filling board vacancies earlier in the year. The Twenty-Fifth Annual General Meeting is scheduled for September 29, 2026.
Historical Stock Returns for TAKE
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.99% | -10.10% | -35.19% | -61.93% | +33.61% | 0.0% |
How will the resolution of the ₹129.2 million disputed income tax assets impact TAKE Limited's future cash flows and balance sheet stability?
What specific milestones must the new AI-driven healthcare platforms achieve to transition from early commercial traction to sustainable, scalable revenue streams?
Given that 61% of net profit came from discontinued operations, what is the projected timeline for the core digital health business to become the primary profit driver?


































